Skip to content
  • Friday, 14 August 2026
  • 11:24 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Monash University Researchers Identify Copper-Based Drug as Potential Breakthrough in Alzheimer’s Treatment by Restoring Brain Waste Removal Systems
Neuroscience & Brain Research

Monash University Researchers Identify Copper-Based Drug as Potential Breakthrough in Alzheimer’s Treatment by Restoring Brain Waste Removal Systems

Rifan Muazin Jun 25, 2026 0

A team of researchers at Monash University has unveiled a significant discovery that could redefine the therapeutic landscape for Alzheimer’s…

Read More
Neuroscience & Brain Research

Copper drug clears toxic Alzheimer’s proteins and restores memory

Rifan Muazin Jun 16, 2026 0

In a significant advancement for neuropharmacology, researchers at Monash University have identified a copper-based drug candidate that demonstrates a dual-action…

Read More
Optimizing spaCy for Production-Grade NLP: Advanced Techniques for Speed and AccuracyNASA-Linked MRI Technology Reveals New Waste Clearance Pathway in the Human BrainQ&A: How 3PLs are navigating the latest pharma trends – Pharmaceutical TechnologyFreediving’s Extreme Physiology Offers Vital Clues to Lung and Heart Function, Potentially Enhancing Treatments for Common Conditions
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ